Navigation Links
HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
Date:6/18/2008

MADISON, N.J., June 18 /PRNewswire-FirstCall/ -- HemoCue(R) AB, a global point-of-care diagnostic test manufacturer and wholly owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that its HemoCue Albumin 201 System is the first quantitative point-of-care test for screening for, diagnosing and monitoring microalbuminuria to be granted a CLIA waiver by the U.S. Food and Drug Administration (FDA). With the FDA CLIA waiver, non-laboratory trained physicians and other health care professionals in any health care facility with a CLIA Certificate of Waiver in the U.S. will be able to use the HemoCue Albumin 201 System to screen patients for microalbuminuria and begin treatment based on the test's results during a single office visit.

Microalbuminuria may indicate the presence of chronic kidney disease (CKD), a life-threatening condition that affects approximately 26 million Americans. Diabetes and hypertension are the two leading risk factors for developing CKD. Microalbuminuria also is an independent risk factor for developing cardiovascular disease in patients with or without diabetes or hypertension.

"Given that microalbuminuria is a risk marker for cardiovascular disease, and its increase over time can indicate kidney disease, it is important that physicians have a fast, easy, reliable test to assess changes in their patients," said professor George L. Bakris, M.D., Director of the Hypertensive Diseases Unit at the University of Chicago-Pritzker School of Medicine. "The availability of a point-of-care test that accurately measures albumin in urine is expected to have a positive impact on physicians' ability to screen in-office and then begin treatment for patients at risk for microalbuminuria, such as
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
2. Xenon Receives BIOTECanada Gold Leaf Award
3. Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
4. Advance Nanotechs Owlstone Subsidiary Receives Order From IEE
5. Met-Pro Corporations Fybroc Business Unit Receives Equipment Order Totaling Approximately $500,000
6. CryoLifes BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
7. Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
8. Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter
9. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
10. Exelixis Receives $150 Million Funding Commitment From Deerfield Management
11. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 Tauriga Sciences, Inc. (OTCQB: TAUG) ... with interests in the natural wellness sector and in ... that its products will be featured at the SEC ... 27 th Annual Growth Stock Conference on March ... 1 Ritz Carlton Drive, Dana Point ...
(Date:2/26/2015)... SAN FRANCISCO, Calif. , Feb. 26, 2015 /PRNewswire/ ... the treatment of cancer, today announced that Sean ... a corporate overview at the upcoming Cowen and Company ... Boston . Dr. McCarthy,s presentation will take ... About CytomX Therapeutics CytomX Therapeutics develops ...
(Date:2/25/2015)... Feb. 25, 2015 /CNW/ - Radient Technologies Inc. (TSX-V: RTI) ... financial results for the third quarter of its fiscal ... Management,s Discussion and Analysis, and the CEO & CFO ... December 31, 2014 are available on www.SEDAR.com ... Appointment The Corporation is also pleased to announce the ...
(Date:2/25/2015)... Market Publishers Ltd is happy to announce that ... have been recently uploaded to its catalogue. , ... . This research report provides wealth of qualitative and ... mortar industry as well as includes an all-round analysis ... It focuses on the main regions such as North ...
Breaking Biology Technology:SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4Radient Technologies Inc. Releases Third Quarter Results and Appoints New Interim CFO 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 3New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 4
... Contributed by G.H. Goldman, R. Geremia, M. ... , ... transformation protocols call for the addition of , ... period of exposure to DNA. However, ...
... Maren Bell and Robert Mortimer, Human Genome Center, Division,of Cell ... , Introduction ... yeast artificial chromosomes (YACs) has traditionally , ... is complicated, often unreliable, and transformation ...
... Contributed by Elizabeth Eustis-Turf*, Kiu-Mei Wang , and Lawrence , ... University of Illinois, Urbana- Champaign, ... into eukaryotic cells permits the study of many , ... ability to insert a gene into a high percentage of ...
Cached Biology Technology:Transformation of Filamentous Fungi by High-Voltage Electroporation 2Transformation of Filamentous Fungi by High-Voltage Electroporation 3Transformation of Filamentous Fungi by High-Voltage Electroporation 4Transformation of Filamentous Fungi by High-Voltage Electroporation 5Transformation of Filamentous Fungi by High-Voltage Electroporation 6Transformation of Filamentous Fungi by High-Voltage Electroporation 7Transformation of Filamentous Fungi by High-Voltage Electroporation 8Electroporation of Yeast Artificial Chromosomes 2Electroporation of Yeast Artificial Chromosomes 3Electroporation of Yeast Artificial Chromosomes 4Electroporation of Primary Bone Marrow Cells 2Electroporation of Primary Bone Marrow Cells 3Electroporation of Primary Bone Marrow Cells 4
(Date:2/18/2015)... Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... speaking at the following conferences, and invited investors to participate ... Boston, MA Tuesday, March 3, 2015 ... Investors Conference, Orlando, FL Wednesday, March ... Live Webcasts To access the live webcasts for these events, ...
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... Acute lung injury caused by cell death, high and ... excess fluid in the lungs (pulmonary edema), may be ... researchers at Yale School of Medicine report in the ... study, which was completed in the laboratory of senior ...
... A first-of-its kind analysis of fifty years of remotely sensed ... in the size and number of more than 10,000 ponds ... and published this week in the Journal of Geophysical Research, ... with recent climate warming in Alaska and may have profound ...
... agent completely prevented the development of bone tumors in ... study, providing early evidence that it could treat, or ... for a number of cancers when they start to ... D. Anderson Cancer Center reported in the journal Cancer ...
Cached Biology News:Key to acute lung injury lies in Ang2 protein 2Shrinking ponds signal warmer, dryer Alaska 2'Trojan Horse' agent halts bone metastasis in mice 2'Trojan Horse' agent halts bone metastasis in mice 3
... solution for scheduling, performing and documenting ... pipettes and liquid handling devices. Collects ... Supports all gravimetric calibration protocols ... NCCLS and GLP requirements Includes ...
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... which belong to the transforming growth ... is a large group of extra-cellular ... of development, reproductive function and tumor ... bone morphogenetic proteins, growth differentiation factors, ...
The new Silencer siRNA Starter Kit is perfect for researchers new to RNAi. It provides all of the reagents, protocols, and instructions necessary to get underway with siRNA transfection and ensure su...
Biology Products: